Functional experiments show that deletion of Osr2 alleviates the exhaustion of tumor-specific CD8+ T cells or CAR-T cells, whereas forced overexpression of Osr2 exacerbates CD8+ T cell exhaustion in solid tumor models. This evidence concerns the gene OSR2 and neoplasm.